3,5-di-(tert-butyl-dimethylsilyloxy)-(3S,5S)-cyclohexan-1-one

We are 3,5-di-(tert-butyl-dimethylsilyloxy)-(3S,5S)-cyclohexan-1-one CAS:139356-35-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3,5-di-(tert-butyl-dimethylsilyloxy)-(3S,5S)-cyclohexan-1-one
CAS.NO:  139356-35-7
Synonyms:
(3S,5S)-3,5-bis[tert-butyl(dimethyl)silyloxy]-cyclohexanone
(3S,5S)-3,5-bis-t-butyldimethylsilyloxy-1-cyclohexanone
(3S,5S)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-cyclohexanone

Molecular Formula: C18H38O3Si2
Molecular Weight:  358.66400

Physical and Chemical Properties:
Density: 0.9±0.1 g/cm3
Boiling point: 361.1±42.0 °C at 760 mmHg
Melting point: /
Flash point: 143.1±23.4 °C
Refractive index: 1.450

Specification:
Appearance:/
Purity:≥/

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Paricalcitol CAS:131918-61-1

Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.14282-76-9 Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.Gabapentin-lactam CAS:64744-50-9 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Diethyl acetamidomalonate The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.